Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Amgen
Related studies linked through entity extraction aliases.
Lipid Management in Renal Transplant Recipients Using Evolocumab.
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)
- Status
- UNKNOWN
- Phase
- PHASE1
TVEC and Preop Radiation for Sarcoma (8 ml Dose)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
- Status
- COMPLETED
- Phase
- PHASE4
Reducing Intracranial atheroSclErosis With Repatha
- Status
- TERMINATED
- Phase
- PHASE4
Blinatumomab Bridging Therapy for BALL
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy
- Status
- UNKNOWN
- Phase
- PHASE4
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
- Status
- RECRUITING
- Phase
- PHASE3
Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL
- Status
- COMPLETED
- Phase
- PHASE1
Myasthenia Gravis Inebilizumab Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
- Status
- COMPLETED
- Phase
- PHASE4
Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE4
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3